tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
PremiumMarket NewsMorning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
2M ago
Mersana Therapeutics downgraded to Neutral from Buy at Guggenheim
Premium
The Fly
Mersana Therapeutics downgraded to Neutral from Buy at Guggenheim
2M ago
Mersana downgraded to Market Perform from Outperform at LifeSci Capital
Premium
The Fly
Mersana downgraded to Market Perform from Outperform at LifeSci Capital
2M ago
Oppenheimer says Day One paying up to $285M for Mersana ‘is interesting’
PremiumThe FlyOppenheimer says Day One paying up to $285M for Mersana ‘is interesting’
2M ago
Mersana Therapeutics downgraded to Neutral from Buy at BTIG
Premium
The Fly
Mersana Therapeutics downgraded to Neutral from Buy at BTIG
2M ago
Mersana Therapeutics up 201% at $26.70 after being acquired by Day One Biopharma
Premium
The Fly
Mersana Therapeutics up 201% at $26.70 after being acquired by Day One Biopharma
2M ago
Day One Biopharmaceuticals to acquire Mersana Therapeutics for up to $285M
PremiumThe FlyDay One Biopharmaceuticals to acquire Mersana Therapeutics for up to $285M
2M ago
MRSN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
MRSN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
Buy Rating for Mersana Therapeutics: Promising Potential in Post-Topo TNBC with Emi-Le ADC
Premium
Ratings
Buy Rating for Mersana Therapeutics: Promising Potential in Post-Topo TNBC with Emi-Le ADC
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100